Neuropilin-1 modulates TGFβ signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy

Glioblastoma (GBM) is a rapidly progressive brain cancer that exploits the neural microenvironment, and particularly blood vessels, for selective growth and survival. Anti-angiogenic agents such as the vascular endothelial growth factor-A (VEGF-A) blocking antibody bevacizumab yield short-term benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwiatkowski, Sam C., Guerrero, Paola A., Hirota, Shinya, Chen, Zhihua, Morales, John E., Aghi, Manish, McCarty, Joseph H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609745/
https://www.ncbi.nlm.nih.gov/pubmed/28938007
http://dx.doi.org/10.1371/journal.pone.0185065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609745/
https://www.ncbi.nlm.nih.gov/pubmed/28938007
http://dx.doi.org/10.1371/journal.pone.0185065

Ejemplares similares